NIH has also kicked in vast sums of capital to help fund that research, though. And actually considering the scale of healthcare spending (3.5T in 2017), you could probably publicly fund drug development outright within the savings window of something like full public funding of healthcare. Total drug R&D expenditure was like 70B in 2017, it's not some giant gift (though appreciated, temper the enthusiasm, so to speak).